Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Nature Communications|April 28, 2016
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancerFergus J Couch, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
American Journal of Human Genetics|December 18, 2018
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesNasim Mavaddat, Kyriaki Michailidou, Joe Dennis, et al.
Nature Genetics|January 9, 2020
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesLaura Fachal, Hugues Aschard, Jonathan Beesley, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerCatherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Nature Communications|April 28, 2016
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancerFergus J Couch, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
American Journal of Human Genetics|December 18, 2018
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesNasim Mavaddat, Kyriaki Michailidou, Joe Dennis, et al.
Nature Genetics|January 9, 2020
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesLaura Fachal, Hugues Aschard, Jonathan Beesley, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerCatherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Pageof 22